Oral Administration of Improves the Effect of Taxane on Preventing the Progression of Breast Cancer and Reduces Its Side Effects

about

Oral Administration of Improves the Effect of Taxane on Preventing the Progression of Breast Cancer and Reduces Its Side Effects

Item

http://www.wikidata.org/entity/Q58801798

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Oral Administration of Improve ...... r and Reduces Its Side Effects

@en

Oral Administration of Improve ...... r and Reduces Its Side Effects

@nl

type

Item

label

Oral Administration of Improve ...... r and Reduces Its Side Effects

@en

Oral Administration of Improve ...... r and Reduces Its Side Effects

@nl

prefLabel

Oral Administration of Improve ...... r and Reduces Its Side Effects

@en

Oral Administration of Improve ...... r and Reduces Its Side Effects

@nl

P1476

Oral Administration of Improve ...... r and Reduces Its Side Effects

@en

P2093

Degang Ji

http://www.w3.org/2001/XMLSchema#string

Jixue Zhao

http://www.w3.org/2001/XMLSchema#string

Lirong Zhang

http://www.w3.org/2001/XMLSchema#string

Xiao Luo

http://www.w3.org/2001/XMLSchema#string

Xin Fu

http://www.w3.org/2001/XMLSchema#string

Xujie Zhai

http://www.w3.org/2001/XMLSchema#string

P2860

Neoadjuvant therapy for early-stage breast cancer: the clinical utility of pertuzumab

Indocyanine green kinetics to assess liver function: Ready for a clinical dynamic assessment in major liver surgery?

14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts.

Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab

Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.

Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases.

Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab.

Soluble Urokinase Receptor and Chronic Kidney Disease.

NF-κB-targeted anti-inflammatory activity of Prunella vulgaris var. lilacina in macrophages RAW 264.7.

Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?

P304

806

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.00806

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30123125

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

P932

6085460

http://www.w3.org/2001/XMLSchema#string